Functional Foods to Increase the Efficacy of Diet in Lowering Serum Cholesterol

Canadian Journal of Cardiology

Volumn 27, Issue 4, 2011, Pages 397-400

  Jenkins, David J A ^a,b,c   Srichaikul, Korbua ^a,b   Mirrahimi, Arash ^a,b   Chiavaroli, Laura ^a,b   Kendall, Cyril W C ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESVERATROL;

ALCOHOLIC BEVERAGE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONGESTIVE CARDIOMYOPATHY; DIET THERAPY; DIETARY INTAKE; EDITORIAL; FUNCTIONAL FOOD; HUMAN; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; OBESITY; SOYBEAN;

CHOLESTEROL; FUNCTIONAL FOOD; HUMANS; HYPERCHOLESTEROLEMIA; TREATMENT OUTCOME;

EID: 80052401655     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.03.008     Document Type: Editorial

References (35)

1. Stampfer M.J., Hu F.B., Manson J.E., et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000, 343:16-22.
2. Willett W.C. Balancing life-style and genomics research for disease prevention. Science 2002, 296:695-698.
3. Raine K.D. Addressing poor nutrition to promote heart health: moving upstream. Can J Cardiol 2010, 26(suppl C):21C-24C.
4. Roth G.A., Fihn S.D., Mokdad A.H., et al. High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries. Bull WHO 2011, 89:92-101.
5. Spence J.D., Jenkins D.J., Davignon J. Dietary cholesterol and egg yolks: not for patients at risk of vascular disease. Can J Cardiol 2010, 26:e336-e339.
6. Willet W.C., Stampfer M.J. Rebuild the food pyramid. Sci Am 2003, 1:64-71.
7. Fraser G.E. Diet, Life Expectancy, and Chronic Disease: Studies of Seventh-Day Adventists and Other Vegetarians 2003, Oxford University Press, New York.
8. Siri-Tarino P.W., Sun Q., Hu F.B., Krauss R.M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010, 91:535-546.
9. Huang J., Frohlich J., Ignasewski A.P. The impact of dietary changes and dietary supplements on lipid profile. Can J Cardiol 2011, 27:488-505.
10. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
11. Jenkins D.J., Kendall C.W., Marchie A., et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 2003, 290:502-510.
12. Jenkins D.J., Chiavaroli L., Wong J.M., et al. Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ 2010, 182:1961-1967.
13. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
14. Kromhout D., Giltay E.J., Geleijnse J.M. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010, 363:2015-2026. Alpha Omega Trial Group.
15. Rauch B., Schiele R., Schneider S., et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010, 122:2152-2159.
16. Varady K.A., Wang Y., Jones P.J. Role of policosanols in the prevention and treatment of cardiovascular disease. Nutr Rev 2003, 61:376-383.
17. Clifton-Bligh P.B., Baber R.J., Fulcher G.R., et al. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001, 8:259-265.
18. Howes J.B., Sullivan D., Lai N., et al. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 2000, 152:143-147.
19. Clerici C., Setchell K.D., Battezzati P.M., et al. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr 2007, 137:2270-2278.
20. Jenkins D.J., Mirrahimi A., Srichaikul K., et al. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 2010, 140:2302S-2311S.
21. Jenkins D.J., Hu F.B., Tapsell L.C., et al. Possible benefit of nuts in type 2 diabetes. J Nutr 2008, 138:1752S-1756S.
22. Jenkins D.J., Kendall C.W., Josse A.R., et al. Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals. J Nutr 2006, 136:2987-2992.
23. Jenkins D.J., Kendall C.W., Marchie A., et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation 2002, 106:1327-1332.
24. Kendall C.W., Esfahani A., Truan J., et al. Health benefits of nuts in prevention and management of diabetes. Asia Pac J Clin Nutr 2010, 19:110-116.
25. Spiller G.A., Jenkins D.A., Bosello O., et al. Nuts and plasma lipids: an almond-based diet lowers LDL-C while preserving HDL-C. J Am Coll Nutr 1998, 17:285-290.
26. Qualified health claims: Letter of enforcement discretion: Nuts and coronary heart disease (docket No. 02P-0505) US Food and Drug Administration (FDA), Accessed January 31, 2011. http://www.fda.gov/Food/LabelingNutrition/LabelClaims/QualifiedHealthClaims/ucm072926.htm.
27. Becker D.J., Gordon R.Y., Halbert S.C., et al. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med 2009, 150:830-839. W147-W9.
28. Heber D., Yip I., Ashley J.M., et al. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 1999, 69:231-236.
29. Bertelli A.A., Giovannini L., Giannessi D., et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tiss React 1995, 17:1-3.
30. Karatzi K., Papamichael C., Aznaouridis K., et al. Constituents of red wine other than alcohol improve endothelial function in patients with coronary artery disease. Coron Artery Dis 2004, 15:485-490.
31. Pace-Asciak C.R., Hahn S., Diamandis E.P., et al. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995, 235:207-219.
32. Jenkins D.J., Kendall C.W., McKeown-Eyssen G., et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 2008, 300:2742-2753.
33. Jenkins D.J., Kendall C.W., Faulkner D.A., et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr 2006, 83:582-591.
34. Trock B.J., Hilakivi-Clarke L., Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006, 98:459-471.
35. Kang X., Zhang Q., Wang S., et al. Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. CMAJ 2010, 182:1857-1862.